chr5-235194-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_004168.4(SDHA):c.1115C>G(p.Pro372Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000898 in 1,613,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004168.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDHA | NM_004168.4 | c.1115C>G | p.Pro372Arg | missense_variant | Exon 9 of 15 | ENST00000264932.11 | NP_004159.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDHA | ENST00000264932.11 | c.1115C>G | p.Pro372Arg | missense_variant | Exon 9 of 15 | 1 | NM_004168.4 | ENSP00000264932.6 | ||
ENSG00000286001 | ENST00000651543.1 | n.1065-1234C>G | intron_variant | Intron 8 of 23 | ENSP00000499215.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251142Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135730
GnomAD4 exome AF: 0.0000937 AC: 137AN: 1461670Hom.: 0 Cov.: 31 AF XY: 0.000110 AC XY: 80AN XY: 727144
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74382
ClinVar
Submissions by phenotype
not provided Uncertain:2
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individuals with paraganglioma, neuroendocrine neoplasm, or ovarian cancer (PMID: 28384794, 29177515, 36947458, 38473309); This variant is associated with the following publications: (PMID: 29177515, 28384794, 36947458, 38473309) -
- -
Dilated cardiomyopathy 1GG;C3279992:Paragangliomas 5;C5543254:Neurodegeneration with ataxia and late-onset optic atrophy;C5700310:Mitochondrial complex II deficiency, nuclear type 1 Uncertain:1
- -
Paragangliomas 5;C5700310:Mitochondrial complex II deficiency, nuclear type 1 Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 372 of the SDHA protein (p.Pro372Arg). This variant is present in population databases (rs141493530, gnomAD 0.009%). This missense change has been observed in individual(s) with paraganglioma-pheochromocytoma syndrome (PMID: 28384794, 29177515). ClinVar contains an entry for this variant (Variation ID: 412361). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SDHA protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Dilated cardiomyopathy 1GG Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.P372R variant (also known as c.1115C>G), located in coding exon 9 of the SDHA gene, results from a C to G substitution at nucleotide position 1115. The proline at codon 372 is replaced by arginine, an amino acid with dissimilar properties. This alteration was identified in a patient with a unilateral pheochromocytoma diagnosed at age 24 and was classified as a variant of uncertain significance by the authors (Bausch B et al. JAMA Oncol, 2017 Sep;3:1204-1212). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Neurodegeneration with ataxia and late-onset optic atrophy Uncertain:1
- -
SDHA-related disorder Uncertain:1
The SDHA c.1115C>G variant is predicted to result in the amino acid substitution p.Pro372Arg. This variant has been reported as a variant of uncertain significance in an individual with head and neck paragangliomas (van der Tuin et al. 2018. PubMed ID: 29177515; Bausch et al. 2017. PubMed ID: 28384794) and in an individual with small bowel cancer (Riechelmann et al. 2023. PubMed ID: 36947458). This variant is reported in 0.0078% of alleles in individuals of European (Non-Finnish) descent in gnomAD, and is interpreted as a variant of uncertain significance by multiple labs in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/412361/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at